Sodium-glucose Co-transporter 2 (SGLT2) inhibitors have gained favor in the management for diabetes due to added benefit in patients with co-morbid cardiovascular and kidney disease. Emerging data indicate that this class of medications may be useful in patients without diabetes. This webinar will discuss available literature evaluating the use of SGLT2 inhibitors in non-diabetic patients with heart failure with reduced ejection fraction (HFrEF) and/or chronic kidney disease (CKD). Also, guidance will be provided on how to effectively implement these agents into formulary considerations and improve access in patient care.
Activity Fee: Member - Free / Non-Member - Not Available
Registration for this webinar will be approved for ASHP Members Only. ASHP member ID number is required to register. Find your ASHP membership ID here.
Not an ASHP member?
Objectives
- Describe the role of SGLT2 inhibitors in management of heart failure with reduced ejection fraction (HFrEF) as a guideline-directed medical therapy.
- Discuss how to incorporate SGLT2 inhibitors into the overall management of chronic kidney disease (CKD).
- Identify formulary considerations related to Sodium-glucose Co-transporter 2 (SGLT2) inhibitors that can improve access to these medications for patients with HFrEF and CKD.
Presenters:
- Sandeep Devabhakthuni, Pharm.D., BCCP, Associate Professor, Cardiology, Director of Postgraduate Training, University of Maryland School of Pharmacy, Baltimore, MD
- Indrani Kar, Pharm.D., Drug Policy/Formulary Specialist, System Pharmacy Services, University Hospitals, Cleveland, Ohio
- Moderator and Speaker: C. Whitney White, Pharm.D., BCPS, Clinical Pharmacy Specialist. Tuscaloosa VA Medical Center, Tuscaloosa, AL
Continuing Education:
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity will provide 1.0 hour (0.1 CEUs) of continuing pharmacy education credits (ACPE#:0204-0000-21-080-L01-P).
Continuing pharmacy education (CPE) for this activity will be processed on ASHP's eLearning portal and reported directly to CPE Monitor. After completion of the live webinar, you will process and claim CPE credit online at elearning.ashp.org. Pharmacists will need the enrollment code that will be announced at the end of the webinar and your eProfile ID from NABP to earn CPE credits. Follow the prompts to claim credit within 60 days after completing the activity.
CE Activity Announcement
The ASHP Section of Inpatient Care Practitioners is recognized for the organization of this webinar continuing education activity.
For questions and comments, please email [email protected].